¶ Introduction
Anti-LGI1 encephalitis is an autoimmune encephalitis syndrome characterized by antibodies targeting leucine-rich glioma inactivated 1 (LGI1), a secreted neuronal protein that functions as an auxiliary subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). Unlike many other autoimmune encephalitides, anti-LGI1 encephalitis is predominantly non-paraneoplastic and affects neurons primarily through functional disruption of synaptic signaling rather than direct immune-mediated cytotoxicity.
This page examines the populations of neurons affected in anti-LGI1 encephalitis, the molecular mechanisms of dysfunction, the characteristic seizure phenotypes, and the pathophysiological basis for cognitive impairment. Understanding these mechanisms provides insight into how disruption of a single synaptic protein can produce widespread network dysfunction and establishes a framework for understanding similar antigenic targets in other autoimmune encephalitides.
¶ Molecular Pathophysiology
¶ LGI1 Protein Biology
LGI1 (leucine-rich glioma inactivated 1) is a 60 kDa secreted neuronal protein encoded by the LGI1 gene located on chromosome 10q24. Despite its name (originally identified in glioma cells), LGI1 is expressed predominantly in the brain and plays critical roles in synaptic development and function. The protein belongs to the leucine-rich repeat (LRR) family and contains multiple protein-protein interaction domains that enable its role as a molecular scaffold at synaptic terminals.
The primary function of LGI1 is its interaction with postsynaptic AMPARs. LGI1 forms a ternary complex with the transmembrane AMPAR regulatory proteins (TARPs), particularly γ-2 (stargazin) and γ-8, which are essential for proper AMPAR trafficking, clustering, and function. This complex is critical for maintaining synaptic AMPAR density, particularly at hippocampal and cortical synapses [1]. LGI1 also interacts with presynaptic ADAM22 (a disintegrin and metalloproteinase 22), creating a trans-synaptic bridge that coordinates pre- and postsynaptic signaling.
¶ Mechanisms of Antibody-Mediated Dysfunction
The antibodies in anti-LGI1 encephalitis are predominantly IgG4 subclass, which do not activate complement and instead exert their effects through functional blockade. The pathophysiological sequence unfolds as follows:
-
Antibody Access to CNS: IgG antibodies cross the blood-brain barrier through a combination of Fc receptor-mediated transcytosis, especially in regions with leaky endothelial junctions (the circumventricular organs, hippocampal formation), and through dynamic regulation of barrier permeability during neuroinflammation [2].
-
LGI1 Binding and Sequestration: Anti-LGI1 antibodies bind to the extracellular domains of LGI1, preventing its interaction with ADAM22 and TARPs. This binding does not necessarily destroy LGI1 but renders it functionally inactive.
-
AMPAR Trafficking Defects: With LGI1 unavailable to stabilize the LGI1-TARP-AMPAR complex, there is progressive loss of synaptic AMPARs, particularly GluA1/GluA2-containing receptors. This reduction is most pronounced at hippocampal CA1 synapses and cortical layer 2/3 pyramidal neuron synapses.
-
Excitatory Synaptic Transmission Impairment: The loss of synaptic AMPARs results in decreased excitatory postsynaptic potentials, altered short-term plasticity, and impaired activity-dependent synaptic strengthening.
-
Network Hyperexcitability: Paradoxically, while individual synapses become less excitatory, the overall network becomes hyperexcitable due to compensatory homeostatic changes and disruption of inhibitory circuit regulation.
¶ Affected Neuron Populations
¶ Hippocampal CA1 Pyramidal Neurons
The CA1 pyramidal neurons are the most severely affected population in anti-LGI1 encephalitis. These neurons express high levels of LGI1 and rely heavily on LGI1-mediated AMPAR trafficking for synaptic integrity.
Electrophysiological Changes:
- Reduced amplitude of evoked excitatory postsynaptic currents (EPSCs)
- Accelerated synaptic depression during trains of stimuli
- Impaired long-term potentiation (LTP) at Schaffer collateral-CA1 synapses
- Enhanced inhibitory input from changed basket cell function
Structural Changes:
- Dendritic spine loss, particularly on oblique dendrites
- Altered spine morphology with reduced head diameter
- Progressive hippocampal atrophy detectable on MRI, particularly in the CA1 subfield [3]
Clinical Correlation: CA1 dysfunction directly underlies the episodic memory impairment that characterizes anti-LGI1 encephalitis. The CA1 region is critical for encoding and retrieving new memories, and its dysfunction produces the distinctive anterograde amnesia seen in this condition.
¶ Temporal Cortex Pyramidal Neurons
Layer 2/3 pyramidal neurons in the temporal neocortex are secondarily affected due to their dense reciprocal connections with the hippocampus and their own expression of LGI1-TARP-AMPAR complexes.
Key Features:
- Disruption of cortico-hippocampal feedforward inhibition
- Altered gamma oscillations (30-80 Hz) critical for memory consolidation
- Impaired integration of multimodal sensory information
Clinical Correlation: Temporal cortical dysfunction contributes to the temporal lobe seizure semiology (automatisms, déjà vu, experiential phenomena) and may underlie the emotional dysregulation seen in some patients.
¶ Hypothalamic Neurons and FBDS Generation
The faciobrachial dystonic seizures (FBDS) characteristic of anti-LGI1 encephalitis arise from dysfunction in hypothalamic circuits, particularly involving the hypothalamus and its connections to the basal ganglia and brainstem.
Key Hypothalamic Regions:
- Tuberal nucleus: Altered output to the globus pallidus interna
- Mammillary bodies: Disrupted mammillothalamic tract signaling
- Arcuate nucleus: Autonomic dysregulation
The FBDS are brief (usually 
seconds), frequent (up to hundreds per day), and involve characteristic dystonic posturing of the arm and ipsilateral facial contraction. This semiology suggests involvement of the corticobasal ganglionic circuits, with hypothalamic dysfunction acting as the trigger or pacemaker for these events.
¶ Thalamic Relay Neurons
Thalamic nuclei, particularly the anterior thalamic nucleus (connected to the mammillary bodies) and medial dorsal nucleus (prefrontal relay), show altered activity patterns in anti-LGI1 encephalitis. This thalamic dysfunction contributes to:
- Disrupted thalamocortical oscillations
- Impaired attention and executive function
- Altered arousal and wakefulness regulation
¶ Cerebellar Purkinje Cells
While less directly involved than limbic structures, cerebellar Purkinje cells express LGI1 and may be affected. Their dysfunction contributes to:
- Altered cerebellar-thalamo-cortical loops
- Potential ataxia or coordination difficulties in severe cases
¶ Seizure Pathophysiology
¶ Faciobrachial Dystonic Seizures (FBDS)
FBDS represent a distinctive seizure type almost exclusive to anti-LGI1 encephalitis. They are characterized by:
- Duration: 1-30 seconds (typically <10 seconds)
- Frequency: Often multiple per hour, up to 100+ per day
- Semiology: Brachial dystonia (arm extension/flexion), ipsilateral facial grimacing
- Consciousness: Typically preserved
- Trigger: Often precipitated by sudden sounds or surprises
The pathophysiology of FBDS involves hypothalamic-subcortical circuits rather than the classic cortical seizure networks. Current evidence suggests:
- Hypothalamic hyperexcitability produces abnormal outputs
- These outputs drive the basal ganglia motor loops inappropriately
- The resulting movement is more accurately described as a paroxysmal dystonia than an epileptic seizure
Importantly, FBDS typically precede the development of full limbic encephalitis by weeks to months, providing a therapeutic window for early intervention [4].
¶ Temporal Lobe Seizures
Classic limbic seizures develop in most patients and arise from hippocampal and temporal cortical dysfunction:
Seizure Onset:
- Mesial temporal structures (hippocampus, amygdala)
- Secondary spread to lateral temporal cortex
Automatisms:
- Oral (lip smacking, chewing, swallowing)
- Manual (fumbling, picking, rubbing)
- Perseveration of prior activity
Post-ictal Features:
- Prolonged confusion
- Anterograde amnesia (especially for events during the seizure)
- Todd's paralysis rare but possible
The hyperexcitability of hippocampal circuits results from the combination of reduced inhibition (loss of feedforward inhibitory circuits reliant on AMPARs) and homeostatic increases in intrinsic excitability.
¶ Secondary Generalization
Approximately 30-40% of patients experience secondary generalized tonic-clonic seizures. The propagation pathway typically involves:
- Limbic system (hippocampus, amygdala)
- Contralateral mesial temporal structures via the fornix and anterior commissure
- Brainstem reticular activating system
- Widespread cortical recruitment
¶ Cognitive Impairment
¶ Memory Dysfunction
The most prominent cognitive deficit in anti-LGI1 encephalitis is anterograde amnesia. The mechanistic basis includes:
- Encoding Failure: CA1 LTP impairment prevents formation of new memory traces
- Consolidation Disruption: Altered hippocampal-neocortical dialogue during sleep
- Retrieval Degradation: Even stored memories become less accessible
Notably, retrograde amnesia for events 1-2 years before onset is common, suggesting that recent memories are more vulnerable than remote ones—consistent with the hippocampal reconsolidation hypothesis.
¶ Executive Function
Prefrontal cortex dysfunction manifests as:
- Impaired set-shifting
- Reduced verbal fluency
- Poor planning and organization
- Disinhibition (in some cases)
These deficits correlate with medial dorsal thalamic involvement and disruption of prefrontal circuits.
¶ Psychiatric Features
Up to 60% of patients develop psychiatric symptoms, including:
- Anxiety and fear (often as prodrome or accompanying FBDS)
- Personality changes
- Psychotic symptoms (less common than in anti-NMDA receptor encephalitis)
¶ Neuroimaging Findings
¶ MRI
Characteristic findings include:
- Hippocampal T2 hyperintensity: Often bilateral, mesial temporal
- Hippocampal atrophy: Progressive in untreated cases
- FLAIR hyperintensities: Temporal lobe white matter
- Cerebellar involvement (less common)
¶ PET
FDG-PET typically shows:
- Hypermetabolism in medial temporal lobes (early stages)
- Hypometabolism in hippocampus and temporal cortex (chronic)
- Frontal hypometabolism with executive dysfunction
¶ EEG
- Temporal lobe interictal epileptiform discharges (80%)
- Focal slowing over temporal regions
- Rarely, electrical status epilepticus during sleep (ESES) pattern
¶ Treatment and Neuronal Recovery
¶ Immunotherapy
First-line treatments target antibody production and remove circulating antibodies:
- Corticosteroids: High-dose intravenous methylprednisolone (1g/day × 3-5 days) followed by oral taper
- Intravenous Immunoglobulin (IVIG): 0.4g/kg/day × 5 days
- Plasma Exchange: Every-other-day exchange for 5-7 sessions
¶ Neuronal Recovery
Neuronal recovery depends on several factors:
- Synaptic Plasticity: Remaining neurons can form new synaptic connections (sprouting)
- Antibody Clearance: As antibodies are removed, LGI1 function gradually recovers
- TARP Expression: New TARP synthesis can partially compensate
Recovery Timeline:
- Seizures often improve within weeks
- Cognitive recovery may take 6-24 months
- Residual deficits common in patients with delayed treatment
¶ Prognostic Factors
Better outcomes associated with:
- Early treatment (within 4 weeks of symptom onset)
- Younger age
- Less hippocampal atrophy at baseline
- Absence of secondary generalization
Worse outcomes associated with:
- Treatment delay >3 months
- Initial refractory seizures
- Significant hippocampal atrophy
- Relapse episodes
¶ Differential Diagnosis and Related Conditions
¶ Other Anti-AMPAR Encephalitis
Anti-LGI1 encephalitis shares features with anti-AMPAR encephalitis (targeting GluA1/GluA2 subunits directly), but has distinct characteristics:
| Feature | Anti-LGI1 | Anti-AMPAR |
|---|---|---|
| FBDS | Common | Rare |
| Tumor association | Low (5-10%) | Higher (50%) |
| CSF findings | Often normal | Often inflammatory |
| Treatment response | Good | Variable |
¶ Anti-ADAM22 Encephalitis
LGI1 interacts with ADAM22; antibodies against ADAM22 itself produce a similar but distinct syndrome, often with more prominent movement disorders.
¶ Genetic LGI1 Epilepsy
Autosomal dominant lateral temporal epilepsy (ADLTE) caused by LGI1 mutations provides insight into the consequences of chronic LGI1 haploinsufficiency. These patients have seizures beginning in adolescence but typically have less cognitive impairment than autoimmune cases.
¶ Cross-Linking Connections
¶ Related Cell Types
- Hippocampal CA1 Pyramidal Neurons
- Temporal Cortex Pyramidal Neurons
- Hypothalamic Orexin Neurons
- Anti-AMPAR Encephalitis-Affected Neurons
- Anti-NMDA Receptor Encephalitis-Affected Neurons
¶ Related Proteins and Pathways
- LGI1
- AMPA Receptors
- [TARPs (γ-2, γ-8)tarp-gamma-8)
- ADAM22
- Synaptic Plasticity Pathways